Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • pancreatic ductal adenocarcinoma

    - PMLiVE

    US researchers develop 3D technique to identify precancerous pancreatic lesions

    PanIN lesions can lead to invasive ductal adenocarcinoma, which affects nearly half a million people globally

    - PMLiVE

    Candel announces promising results for immunotherapy candidate in pancreatic cancer

    Pancreatic cancer accounts for approximately 3.3% of all new cancer cases

    - PMLiVE

    Nanobiotix shares promising results for radiotherapy enhancer in advanced pancreatic cancer

    More than 90% of patients with locally advanced disease are not eligible for surgery

    - PMLiVE

    Ipsen reports positive phase 3 data for Onivyde in pancreatic cancer

    The investigational treatment regimen met its primary endpoint of overall survival

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links